Antioxidants and HNE in redox homeostasis

Free Radical Biology and Medicine

Volumn 111, Issue , 2017, Pages 87-101

  Łuczaj, Wojciech ^a   Gęgotek, Agnieszka ^a   Skrzydlewska, Elżbieta ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

4 hydroxy 2 nonenal; Antioxidants; Lipid peroxidation; Redox homeostasis, Transcription factors

Indexed keywords

4 HYDROXYNONENAL; ANTIOXIDANT; HEAT SHOCK TRANSCRIPTION FACTOR 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; NUCLEIC ACID; PHOSPHOLIPID; PROTEIN KINASE C; PROTEIN P53; REDOX EFFECTOR FACTOR 1; TRANSCRIPTION FACTOR NRF2; 4-HYDROXY-2-NONENAL; ALDEHYDE; APOPTOSIS REGULATORY PROTEIN; MEMBRANE LIPID; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR;

AGING; CHEMICAL MODIFICATION; ENZYME ACTIVATION; HOMEOSTASIS; HUMAN; LIPID PEROXIDATION; MACROMOLECULE; METABOLISM; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN MODIFICATION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; GENE EXPRESSION REGULATION; GENETICS; OXIDATIVE STRESS;

AGING; ALDEHYDES; ANIMALS; ANTIOXIDANTS; APOPTOSIS REGULATORY PROTEINS; GENE EXPRESSION REGULATION; HOMEOSTASIS; HUMANS; LIPID PEROXIDATION; MEMBRANE LIPIDS; METABOLIC NETWORKS AND PATHWAYS; OXIDATION-REDUCTION; OXIDATIVE STRESS; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 85007135376     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2016.11.033     Document Type: Review

References (237)

1. Halliwell, B., Free radicals and antioxidants – quo vadis?. Trends Pharmacol. Sci. 32 (2011), 125–130.
2. Niki, E., Lipid peroxidation: physiological levels and dual biological effects. Free Radic. Biol. Med. 47 (2009), 469–484.
3. Ozcan, A., Ogun, M., Biochemistry of reactive oxygen and nitrogen species. Joghi, S., Gowder, T., (eds.) Basic Principles and Clinical Significance of Oxidative Stress, 2015, InTech, 10.5772/61193 http://www.intechopen.com/books/basic-principles-and-clinical-significance-of-oxidative-stress/biochemistry-of-reactive-oxygen-and-nitrogen-species.
4. Sultana, R., Perluigi, M., Butterfield, D.A., Lipid peroxidation triggers neurodegeneration: a redox proteomics view into the Alzheimer disease brain. Free Radic. Biol. Med. 62 (2013), 157–169.
5. Bhattacharya, S., Reactive oxygen species and cellular defense system. Rani, V., Yadav, U.C.S., (eds.) Free Radicals in Human Health and Disease, 2015, Springer, India.
6. Reis, A., Spickett, C.M., Chemistry of phospholipid oxidation. Biochim. Biophys. Acta (BBA)-Biomembr. 1818 (2012), 2374–2387.
7. Ayala, A., Muñoz, M.F., Argüelles, S., Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid. Med. Cell. Longev., 2014, 10.1155/2014/360438.
8. Esterbauer, H., Benedetti, A., Lang, J., Fulceri, R., Fauler, G., Comporti, M., Studies on the mechanism of formation of 4-hydroxynonenal during microsomal lipid peroxidation. Biochim. Biophys. Acta 876 (1986), 154–166.
9. Esterbauer, Zollner, H., Schaur, R.J., Aldehydes Formed by Lipid Peroxidation: Mechanisms of Formation, Occurrence and Determination. 1990, CRC Press, Boca Raton, FL.
10. Pryor, W.A., Porter, N.A., Suggested mechanisms for the production of 4-hydroxy-2-nonenal from the autoxidation of polyunsaturated fatty acids. Free Radic. Biol. Med. 8 (1990), 541–543.
11. Loidl-Stahlhofen, A., Hannemann, K., Spiteller, G., Generation of alphahydroxyaldehydic compounds in the course of lipid peroxidation. Biochim. Biophys. Acta 1213 (1994), 140–148.
12. Kaur, K., Salomon, R.G., O'Neil, J., Hoff, H.F., (Carboxyalkyl)pyrroles in human plasma and oxidized low-density lipoproteins. Chem. Res. Toxicol. 10 (1997), 1387–1396.
13. Schneider, C., Tallman, K.A., Porter, N.A., Brash, A.R., Two distinct pathways of formation of 4-hydroxynonenal. Mechanisms of nonenzymatic transformation of the 9- and 13-hydroperoxides of linoleic acid to 4-hydroxyalkenals. J. Biol. Chem. 276 (2001), 20831–20838.
14. Riahi, Y., Cohen, G., Shamni, O., Sasson, S., Signaling and cytotoxic functions of 4-hydroxyalkenals. Am. J. Physiol. Endocrinol. Metab. 299 (2010), E879–E886.
15. Wang, X., Allen, T.D., Yang, Y., Moore, D.R., Huycke, M.M., Cyclooxygenase-2 generates the endogenous mutagen trans-4-hydroxy-2-nonenal in Enterococcus faecalis-infected macrophages., 6, 2013, 206–216.
16. Zhong, H., Lu, J., Xia, L., Zhu, M., Yin, H., Formation of electrophilic oxidation products from mitochondrial cardiolipin in vitro and in vivo in the context of apoptosis and atherosclerosis. Redox Biol. 2 (2014), 2878–2883.
17. Patterson, E., Wall, R., Fitzgerald, G.F., Ross, R.P., Stanton, C., Health implications of high dietary omega-6 polyunsaturated fatty acids. J. Nutr. Metab., 2012, 2012.
18. Allen, B.G., Bhatia, S.K., Buatti, J.M., Brandt, K.E., Lindholm, K.E., Button, A.M., Szweda, L.I., Smith, B.J., Spitz, D.R., Fath, M.A., Ketogenic diets enhance oxidative stress and radio-chemo-therapy responses in lung cancer xenografts. Clin. Cancer Res. 19 (2013), 3905–3913.
19. Jin, Z., Berthiaume, J.M., Li, Q., Henry, F., Huang, Z., Sadhukhan, S., et al. Catabolism of (2E)-4-hydroxy-2-nonenal via omegaand omega-1-oxidation stimulated by ketogenic diet. J. Biol. Chem. 289 (2014), 32327–32338.
20. Bosch-Morell, F., Flohé, L., Marín, N., Romero, F.J., 4-Hydroxynonenal inhibits glutathione peroxidase: protection by glutathione. Free Radic. Biol. Med. 26 (1999), 1383–1387.
21. Chen, L., Hambright, W.S., Na, R., Ran, Q., Ablation of the ferroptosis inhibitor glutathione peroxidase 4 in neurons results in rapid motor neuron degeneration and paralysis. J. Biol. Chem. 290 (2015), 28097–28106.
22. Biernacki, M., Łuczaj, W., Gęgotek, A., Toczek, M., Bielawska, K., Skrzydlewska, E., Crosstalk between liver antioxidant and the endocannabinoid systems after chronic administration of the FAAH inhibitor, URB597, to hypertensive rats. Toxicol. Appl. Pharmacol. 301 (2016), 31–41.
23. Moniuszko-Malinowska, A., Łuczaj, W., Jarocka-Karpowicz, I., Pancewicz, S., Zajkowska, J., Andrisic, L., et al. Lipid peroxidation in the pathogenesis of neuroborreliosis. Free Radic. Biol. Med. 96 (2016), 255–263.
24. Gęgotek, A., Biernacki, M., Ambrożewicz, E., Surażyński, A., Wroński, A., Skrzydlewska, E., The cross-talk between electrophiles, antioxidant defence and the endocannabinoid system in fibroblasts and keratinocytes after UVA and UVB irradiation. J. Dermatol. Sci. 81 (2016), 107–117.
25. Gęgotek, A., Nikliński, J., Žarković, N., Žarković, K., Waeg, G., Łuczaj, W., et al. Lipid mediators involved in the oxidative stress and antioxidant defence of human lung cancer cells. Redox Biol. 9 (2016), 210–219.
26. Yadav, U.C., Ramana, K.V., Awasthi, Y.C., Srivastava, S.K., Glutathione level regulates HNE-induced genotoxicity in human erythroleukemia cells. Toxicol. Appl. Pharmacol. 227 (2008), 257–264.
27. Deponte, M., Glutathione catalysis and the reaction mechanisms of glutathione-dependent enzymes. Biochim. Biophys. Acta (BBA)-Gen. Subj. 1830 (2013), 3217–3266.
28. Srivastava, S., Ramana, K.V., Bhatnagar, A., Srivastava, S.K., Synthesis, quantification, characterization, and signaling properties of glutathionyl conjugates of enals. Methods Enzymol. 474 (2010), 297–313.
29. Lee, H.P., Pancholi, N., Esposito, L., Previll, L.A., Wang, X., Zhu, X., et al. Early induction of oxidative stress in mouse model of Alzheimer disease with reduced mitochondrial superoxide dismutase activity. PLoS One, 7, 2012, e28033.
30. Hao, E., Mukhopadhyay, P., Cao, Z., Erdélyi, K., Holovac, E., Liaudet, L., et al. Cannabidiol protects against doxorubicin-induced cardiomyopathy by modulating mitochondrial function and biogenesis. Mol. Med. 21 (2015), 38–45.
31. Zheng, R., Heck, D.E., Mishin, V., Black, A.T., Shakarjian, M.P., Kong, A.N., et al. Modulation of keratinocyte expression of antioxidants by 4-hydroxynonenal, a lipid peroxidation end product. Toxicol. Appl. Pharmacol. 275 (2014), 113–121.
32. Zhang, H., Dickinson, D.A., Liu, R.M., Forman, H.J., 4-Hydroxynonenal increases γ-glutamyl transpeptidase gene expression through mitogen-activated protein kinase pathways. Free Radic. Biol. Med. 38 (2005), 463–471.
33. Sultana, R., Butterfield, D.A., Oxidatively modified GST and MRP1 in Alzheimer's disease brain: Implications for accumulation of reactive lipid peroxidation products. Neurochem. Res. 29 (2004), 2215–2220.
34. Bauer, G., Zarkovic, N., Revealing mechanisms of selective, concentration-dependent potentials of 4-hydroxy-2-nonenal to induce apoptosis in cancer cells through inactivation of membrane-associated catalase. Free Radic. Biol. Med. 81 (2015), 128–144.
35. D'souza, A., Kurien, B.T., Rodgers, R., Shenoi, J., Kurono, S., Matsumoto, H., et al. Detection of catalase as a major protein target of the lipid peroxidation product 4-HNE and the lack of its genetic association as a risk factor in SLE. BMC Med. Genet. 9 (2008), 62–70.
36. Fang, J., Holmgren, A., Inhibition of thioredoxin and thioredoxin reductase by 4-hydroxy-2-nonenal in vitro and in vivo. J. Am. Chem. Soc. 128 (2006), 879–1885.
37. Qin, H., Zhang, X., Ye, F., Zhong, L., High‐fat diet‐induced changes in liver thioredoxin and thioredoxin reductase as a novel feature of insulin resistance. FEBS Open Biol. 4 (2014), 928–935.
38. Sugano, E., Isago, H., Murayama, N., Tamai, M., Tomita, H., Different anti-oxidant effects of thioredoxin 1 and thioredoxin 2 in retinal epithelial cells. Cell Struct. Funct. 38 (2013), 81–88.
39. Galam, L., Failla, A., Soundararajan, R., Lockey, R.F., Kolliputi, N., 4-hydroxynonenal regulates mitochondrial function in human small airway epithelial cells. Oncotarget 6 (2015), 41508–41521.
40. Sugano, E., Murayama, N., Takahashi, M., Tabata, K., Tamai, M., Tomita, H., Essential role of thioredoxin 2 in mitigating oxidative stress in retinal epithelial cells. J. Ophthalmol., 2013, 2013, 185825.
41. Wang, D., Ma, Y., Yang, X., Xu, X., Zhao, Y., Zhu, Z., et al. Hypermethylation of the Keap1 gene inactivates its function, promotes Nrf2 nuclear accumulation, and is involved in arsenite-induced human keratinocyte transformation. Free Radic. Biol. Med. 89 (2015), 209–219.
42. Traber, M.G., Stevens, J.F., Vitamins C and E: beneficial effects from a mechanistic perspective. Free Radic. Biol. Med. 51 (2011), 1000–1013.
43. Odetti, P., Traverso, N., Monacelli, F., Menini, S., Vazzana, J., Tasso, B., et al. Vitamin E-coated filter decreases levels of free 4-hydroxyl-2-nonenal during haemodialysis sessions. Free Radic. Res. 40 (2006), 207–212.
44. Meganathan, P., Fu, J.Y., Biological properties of tocotrienols: evidence in human studies. Int. J. Mol. Sci., 17, 2016, 1682.
45. Figueroa-Méndez, R., Rivas-Arancibia, S., Vitamin C in health and disease: its role in the metabolism of cells and redox state in the brain. Front. Physiol., 6, 2015, 397.
46. Milkovic, L., Siems, W., Siems, R., Zarkovic, N., Oxidative stress and antioxidants in carcinogenesis and integrative therapy of cancer. Curr. Pharm. Des. 20 (2014), 6529–6542.
47. Neveu, V., Perez-Jimenez, J., Vos, F., Crespy, V., du Chaffaut, L., Mennen, L., Knox, C., Eisner, R., Cruz, J., Wishart, D., et al. Phenol-explorer: an online comprehensive database on polyphenol contents in foods. Database, 2010, 2010, bap024.
48. Pisoschi, A.M., Pop, A., The role of antioxidants in the chemistry of oxidative stress: a review. Eur. J. Med. Chem. 97 (2015), 55–74.
49. Łuczaj, W., Siemieniuk, E., Roszkowska-Jakimiec, W., Skrzydlewska, E., Protective effect of black tea against ethanol-induced oxidative modifications of liver proteins and lipids. J. Stud. Alcohol 67 (2006), 510–518.
50. Augustyniak, A., Ostrowska, J., Łuczaj, W., Skrzydlewska, E., Comparison of antioxidative properties of green and black tea. Panglossi, H.V., (eds.) Leading Edge Antioxidants Research, 2007, Nova Science Publishers, New York, 17–34.
51. Lin, B.W., Gong, C.C., Song, H.F., Cui, Y.Y., Effects of anthocyanins on the prevention and treatment of cancer. Br. J. Pharmacol., 2016, 10.1111/bph.13627 [Epub ahead of print].
52. Ambrożewicz, E., Augustyniak, A., Gęgotek, A., Bielawska, K., Skrzydlewska, E., Black-currant protection against oxidative stress formation. J. Toxicol. Environ. Health Part A 76 (2013), 1293–1306.
53. Khan, M.S., Ali, T., Kim, M.W., Jo, M.H., Jo, M.G., Badshah, H., Kim, M.O., Anthocyanins protect against LPS-induced oxidative stress-mediated neuroinflammation and neurodegeneration in the adult mouse cortex. Neurochem. Int. 2016:100 (2016), 1–10.
54. Diaz, M., Degens, H., Vanhees, L., Austin, C., Azzawi, M., The effects of resveratrol on aging vessels. Exp. Gerontol. 85 (2016), 41–47.
55. Hytti, M., Piippo, N., Salminen, A., Honkakoski, P., Kaarniranta, K., Kauppinen, A., Quercetin alleviates 4-hydroxynonenal-induced cytotoxicity and inflammation in ARPE-19 cells. Exp. Eye Res. 132 (2015), 208–215.
56. García-Lafuente, A., Guillamón, E., Villares, A., Rostagno, M.A., Martínez, J.A., Flavonoids as anti-inflammatory agents: implications in cancer and cardiovascular disease. Inflamm. Res. 58 (2009), 537–552.
57. Ding, J., Zhang, Q., Luo, Q., Ying, Y., Liu, Y., Li, Y., Wei, W., Yan, F., Zhang, H., Alda-1 attenuates lung ischemia-reperfusion injury by reducing 4-hydroxy-2-nonenal in alveolar epithelial cells. Crit. Care Med. 44 (2016), 544–552.
58. Bouayed, J., Bohn, T., Exogenous antioxidants—double-edged swords in cellular redox state: health beneficial effects at physiologic doses versus deleterious effects at high doses. Oxid. Med. Cell. Longev. 3 (2010), 228–237.
59. Zhou, Y., Zheng, J., Li, Y., Xu, D.P., Li, S., Chen, Y.M., Li, H.B., Natural polyphenols for prevention and treatment of cancer. Nutrients, 8, 2016, 515.
60. Lambert, J.D., Elias, R.J.D., The antioxidant and pro-oxidant activities of green tea polyphenols: a role in cancer prevention. Arch. Biochem. Biophys. 501 (2010), 65–72.
61. Petersen, D.R., Doorn, J.A., Reactions of 4-hydroxynonenal with proteins and cellular targets. Free Radic. Biol. Med. 37 (2004), 937–945.
62. Barrera, G., Pizzimenti, S., Ciamporcero, E.S., Daga, M., Ullio, C., Arcaro, A., et al. Role of 4-hydroxynonenal-protein adducts in human diseases. Antioxid. Redox Signal. 22 (2015), 1681–1702.
63. Yang, Y., Sharma, R., Sharma, A., Awasthi, S., Awasthi, Y.C., Lipid peroxidation and cell cycle signaling: 4-hydroxynonenal, a key molecule in stress mediated signaling. Acta Biochim. Pol. 50 (2003), 319–336.
64. Mattson, M.P., Roles of the lipid peroxidation product 4-hydroxynonenal in obesity, the metabolic syndrome, and associated vascular and neurodegenerative disorders. Exp. Gerontol. 44 (2009), 625–633.
65. Valko, M., Leibfritz, D., Moncol, J., Cronin, M.T., Mazur, M., Telser, J., Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 39 (2007), 44–84.
66. Poli, G., Schaur, R.J., Siems, W.G., Leonarduzzi, G., 4-Hydroxynonenal: a membrane lipid oxidation product of medicinal interest. Med. Res. Rev. 28 (2008), 569–631.
67. Vatsyayan, R., Lelsani, P.C., Chaudhary, P., Kumar, S., Awasthi, S., Awasthi, Y.C., The expression and function of vascular endothelial growth factor in retinal pigment epithelial (RPE) cells is regulated by 4-hydroxynonenal (HNE) and glutathione S-transferaseA4-4. Biochem. Biophys. Res. Commun. 417 (2012), 346–351.
68. Singh, S.P., Chen, T., Chen, L., Mei, N., McLain, E., Samokyszyn, V., et al. Mutagenic effects of 4-hydroxynonenal triacetate, a chemically protected form of the lipid peroxidation product 4-hydroxynonenal, as assayed in L5178Y/Tk+/− mouse lymphoma cells. J. Pharmacol. Exp. Ther. 313 (2005), 855–861.
69. Schaur, R.J., Basic aspects of the biochemical reactivity of 4-hydroxynonenal. Mol. Asp. Med. 24 (2003), 149–159.
70. Esterbauer, H., Schaur, R.J., Zollner, H., Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med. 11 (1991), 81–128.
71. Siems, W., Grune, T., Intracellular metabolism of 4-hydroxynonenal. Mol. Asp. Med. 24 (2003), 167–175.
72. Alary, J., Debrauwer, L., Fernandez, Y., Paris, A., Cravedi, J.P., Dolo, L., et al. Identification of novel urinary metabolites of the lipid peroxidation product 4-hydroxy-2-nonenal in rat. Chem. Res. Toxicol. 11 (1998), 1368–1376.
73. Balogh, L.M., Atkins, W.M., Interactions of glutathione transferases with 4-hydroxynonenal. Drug Metab. Rev. 43 (2011), 165–178.
74. McElhanon, K.E., Bose, C., Sharma, R., Wu, L., Awasthi, Y.C., Singh, S.P., Gsta4nullmouse embryonicfibroblasts exhibit enhanced sensitivity to oxidants: role of 4-hydroxynonenal in oxidant toxicity. Open J. Apoptosis, 2, 2013, 1, 10.4236/ojapo.2013.21001.
75. Frohnert, B.I., Bernlohr, D.A., Glutathionylated products of lipid peroxidation: a novel mechanism of adipocyte to macrophage signaling. Adipocyte 3 (2014), 224–229.
76. Sadhukhan, S., Han, Y., Jin, Z., Tochtrop, G.P., Zhang, G.F., Glutathionylated 4-hydroxy-2-(E)-alkenal enantiomers in rat organs and their contributions toward the disposal of 4-hydroxy-2-(E)-nonenal in rat liver. Free Radic. Biol. Med. 70 (2014), 78–85.
77. Zhang, Y.K., Wang, Y.J., Gupta, P., Chen, Z.S., Multidrug resistance proteins (MRPs) and cancer therapy. AAPS J. 17 (2015), 802–812.
78. Zhang, H., Forman, H.J., Submicromolar concentrations of 4-hydroxynonenal induce glutamate cysteine ligase expression in HBE1 cells. Redox Rep. 12 (2013), 101–106.
79. Singh, P., Sharma, R., McElhanon, K., Allen, C.D., Megyesi, J.K., Beneš, H., et al. Sulforaphane protects the heart from doxorubicin-induced toxicity. Free Radic. Biol. Med. 86 (2015), 90–101.
80. Sen, S., Kawahara, B., Gupta, D., Tsai, R., Khachatryan, M., Roy-Chowdhuri, S., et al. Role of cystathionine β-synthase in human breast cancer. Free Radic. Biol. Med. 86 (2015), 228–238.
81. Pillon, N.J., Croze, M.L., Vella, R.E., Soulère, L., Lagarde, M., Soulage, C.O., The lipid peroxidation by-product 4-hydroxy-2-nonenal (4-HNE) induces insulin resistance in skeletal muscle through both carbonyl and oxidative stress. Endocrinology 153 (2012), 2099–2111.
82. Iles, K.E., Liu, R.M., Mechanisms of glutamate cysteine ligase (GCL) induction by 4-hydroxynonenal. Free Radic. Biol. Med. 38 (2005), 547–556.
83. Beneš, H., Vuong, M.K., Boerma, M., McElhanon, K.E., Siegel, E.R., Singh, S.P., Protection from oxidative and electrophilic stress in the Gsta4-null mouse heart. Cardiovasc. Toxicol. 13 (2013), 347–356.
84. Kong, D., Kotraiah, V., Modulation of aldehyde dehydrogenase activity affects (±)-4-Hydroxy-2E-nonenal (HNE) toxicity and HNE–protein adduct levels in PC12 cells. J. Mol. Neurosci. 47 (2012), 595–603.
85. Murphy, T.C., Amarnath, V., Gibson, K.M., Picklo, M.J. Sr., Oxidation of 4-hydroxy-2-nonenal by succinic semialdehyde dehydrogenase (ALDH5A). J. Neurochem. 86 (2003), 298–305.
86. Al Nimer, F., Strom, M., Lindblom, R., Aeinehband, S., Bellander, B.M., Nyengaard, J.R., et al. Naturally occurring variation in the glutathione-s-transferase 4 gene determines neurodegeneration after traumatic brain injury. Antioxid. Redox Signal. 18 (2013), 784–794.
87. Dick, R.A., Kwak, M.K., Sutter, T.R., Kensler, T.W., Antioxidative function and substrate specificity of NAD(P)Hdependent alkenal/one oxidoreductase. A new role for leukotriene B4 12-hydroxydehydrogenase/15-oxoprostaglandin 13-reductase. J. Biol. Chem. 276 (2001), 40803–40810.
88. Amunom, I., Stephens, L.J., Tamasi, V., Cai, J., Pierce, W.M., Conklin, D.J., Prough, R.A., Cytochromes P450 catalyze oxidation of α, β-unsaturated aldehydes. Arch. Biochem. Biophys. 464 (2007), 187–196.
89. Amunom, I., Dieter, L.J., Tamasi, V., Cai, J., Conklin, D.J., Srivastava, S., et al. Cytochromes P450 catalyze the reduction of alpha, betaunsaturated aldehydes. Chem. Res. Toxicol. 24 (2011), 1223–1230.
90. Baradat, M., Jouanin, I., Dalleau, S., Tache, S., Gieules, M., Debrauwer, L., et al. 4-Hydroxy-2(E)-nonenal metabolism differs in Apc(þ/þ) cells and in Apc(Min/þ) cells: it may explain colon cancer promotion by heme iron. Chem. Res. Toxicol. 24 (2011), 1984–1993.
91. Zhang, G.F., Kombu, R.S., Kasumov, T., Han, Y., Sadhukhan, S., Zhang, J., et al. Catabolism of 4-hydroxyacids and 4-hydroxynonenal via 4-hydroxy-4-phosphoacyl-CoAs. J. Biol. Chem. 284 (2009), 33521–33534.
92. Berthiaume, J.M., Li, Q., Sadhukhan, S., Henry, F., Tochtrop, G.P., Brunengraber, H., et al. Catabolism of 4-hydroxy-2(E)-nonenal (HNE) via omega oxidation in perfused rat livers. FASEB J., 27(Suppl 794), 2013, S15.
93. Castegna, A., Lauderback, C.M., Mohmmad-Abdul, H., Butterfield, D.A., Modulation of phospholipid asymmetry in synaptosomal membranes by the lipid peroxidation products, 4-hydroxynonenal and acrolein: implications for Alzheimer's disease. Brain Res. 1004 (2004), 193–197.
94. Guichardant, M., Bacot, S., Molière, P., Lagarde, M., Hydroxy-alkenals from the peroxidation of n-3 and n-6 fatty acids and urinary metabolites. Prostaglandins Leukot. Essent. Fatty Acids 75 (2006), 179–182.
95. Bacot, S., Bernoud-Hubac, N., Chantegrel, B., Deshayes, C., Doutheau, A., Ponsin, M.G., et al. Evidence for in situ ethanolamine phospholipid adducts with hydroxy-alkenals. J. Lipid Res. 48 (2007), 816–825.
96. Guichardant, M., Bernoud-Hubac, N., Chantegrel, B., Deshayes, C., Lagarde, M., Aldehydes from n-6 fatty acid peroxidation. Effects on aminophospholipids. Prostaglandins Leukot. Essent. Fatty Acids 67 (2002), 147–149.
97. Muto, M., Takahashi, M., Ohtsu, A., Ebihara, S., Yoshida, S., Esumi, H., Risk of multiple squamous cell carcinomas both in the esophagus and the head and neck region. Carcinogenesis 26 (2005), 1008–1012.
98. Zhong, H., Yin, H., Role of lipid peroxidation derived 4-hydroxynonenal (4-HNE) in cancer: Focusing on mitochondria. Redox Biol. 4 (2015), 193–199.
99. Banerjee, S., Christov, P.P., Kozekova, A., Rizzo, C.J., Egli, M., Stone, M.P., Replication bypass of the trans-4-hydroxynonenal-derived (6 S, 8 R, 11 S)-1, N 2-deoxyguanosine DNA adduct by the sulfolobus solfataricus DNA polymerase IV. Chem. Res. Toxicol. 25 (2012), 422–435.
100. Gros, L., Ishchenko, A.A., Saparbaev, M., Enzymology of repair of etheno-adducts. Mutat. Res. 531 (2003), 219–229.
101. Nair, J., Srivatanakul, P., Haas, C., Jedpiyawongse, A., Khuhaprema, T., Seitz, H.K., Bartsch, H., High urinary excretion of lipid peroxidation-derived DNA damage in patients with cancer-prone liver diseases. Mutat. Res. 683 (2010), 23–28.
102. Linhart, K.B., Glassen, K., Peccerella, T., Waldherr, R., Linhart, H., Bartsch, H., et al. The generation of carcinogenic etheno-DNA adducts in the liver of patients with nonalcoholic fatty liver disease. Hepatobiliary Surg. Nutr. 2015:4 (2015), 117–123.
103. Temviriyanukul, P., Meijers, M., van Hees-Stuivenberg, S., Boei, J.J., Delbos, F., Ohmori, H., et al. Different sets of translesion synthesis DNA polymerases protect from genome instability induced by distinct food-derived genotoxins. Toxicol. Sci. 127 (2012), 130–138.
104. Minko, I.G., Kozekov, I.D., Harris, T.M., Rizzo, C.J., Lloyd, R.S., Stone, M.P., Chemistry and biology of DNA containing 1, N 2-deoxyguanosine adducts of the α, β-unsaturated aldehydes acrolein, crotonaldehyde, and 4-hydroxynonenal. Chem. Res. Toxicol. 22 (2009), 759–778.
105. Hu, W., Feng, Z., Eveleigh, J., Iyer, G., Pan, J., Amin, S., et al. The major lipid peroxidation product, trans-4-hydroxy-2-nonenal, preferentially forms DNA adducts at codon 249 of human p53 gene, a unique mutational hotspot in hepatocellular carcinoma. Carcinogenesis 23 (2002), 1781–1789.
106. Balbo, S., Turesky, R.J., Villalta, P.W., DNA Adductomics. Chem. Res. Toxicol. 27 (2014), 356–366.
107. Chung, F.L., Nath, R.G., Ocando, J., Nishikawa, A., Zhang, L., Deoxyguanosine adducts of t-4-hydroxy-2-nonenal are endogenous DNA lesions in rodents and humans: Detection and potential sources. Cancer Res. 60 (2000), 1507–1511.
108. Choudhury, S., Dyba, M., Pan, J., Roy, R., Chung, F.L., Repair kinetics of acrolein- and (E)-4-hydroxy-2-nonenal-derived DNA adducts in human colon cell extracts. Mutat. Res. 751–752 (2013), 15–23.
109. Feng, Z., Hu, W., Amin, S., Tang, M.S., Mutational spectrum and genotoxicity of the major lipid peroxidation product, trans-4-hydroxy-2-nonenal, induced DNA adducts in nucleotide excision repair-proficient and -deficient human cells. Biochemistry 42 (2003), 7848–7854.
110. Dong, D., Zhong, W., Sun, Q., Zhang, W., Sun, X., Zhou, Z., Oxidative products from alcohol metabolism differentially modulate pro-inflammatory cytokine expression in Kupffer cells and hepatocytes. Cytokine 85 (2016), 109–119.
111. Smith, B.C., Denu, J.M., Chemical mechanisms of histone lysine and arginine modifications. Biochim. Biophys. Acta 1789 (2009), 45–57.
112. Alzolibani, A.A., Al Robaee, A.A., Al-Shobaili, H.A., Rasheed, Z., 4-hydroxy-2-nonenal modified histone-H2A: a possible antigenic stimulus for systemic lupus erythematosus autoantibodies. Cell. Immunol. 284 (2013), 154–162.
113. Tessarz, P., Kouzarides, T., Histone core modifications regulating nucleosome structure and dynamics. Nat. Rev. Mol. Cell. Biol. 15 (2014), 703–708.
114. Baker, M.A., Weinberg, A., Hetherington, L., Villaverde, A.I., Velkov, T., Baell, J., et al. Defining the mechanisms by which the reactive oxygen species by-product, 4-hydroxynonenal, affects human sperm cell function. Biol. Reprod., 92, 2015, 108.
115. Rauniyar, N., Prokai, L., Detection and identification of 4‐hydroxy‐2‐nonenal Schiff‐base adducts along with products of Michael addition using data‐dependent neutral loss‐driven MS3 acquisition: Method evaluation through an in vitro study on cytochrome c oxidase modifications. Proteomics 9 (2009), 5188–5193.
116. Guéraud, F., Atalay, M., Bresgen, N., Cipak, A., Eckl, P.M., Huc, L., et al. Chemistry and biochemistry of lipid peroxidation products. Free Radic. Res. 44 (2010), 1098–1124.
117. Tang, X., Sayre, L.M., Tochtrop, G.P., A mass spectrometric analysis of 4-hydroxy-2-(E)-nonenal modification of cytochrome c. J. Mass Spectrom. 46 (2011), 290–297.
118. Fritz, K.S., Petersen, D.R., Exploring the biology of lipid peroxidation-derived protein carbonylation. Chem. Res. Toxicol. 24 (2011), 1411–1419.
119. Doorn, J.A., Petersen, D.R., Covalent modification of amino acid nucleophiles by the lipid peroxidation products 4-hydroxy-2-nonenal and 4-oxo-2-nonenal. Chem. Res. Toxicol. 15 (2002), 1445–1450.
120. Aldini, G., Gamberoni, L., Orioli, M., Beretta, G., Regazzoni, L., Maffei Facino, R., et al. Mass spectrometric characterization of covalent modification of human serum albumin by 4-hydroxy-trans-2-nonenal. J. Mass Spectrom. 41 (2006), 1149–1161.
121. Ishii, T., Ito, S., Kumazawa, S., Sakurai, T., Yamaguchi, S., Mori, T., et al. Site-specific modification of positively-charged surfaces on human serum albumin by malondialdehyde. Biochem. Biophys. Res. Commun. 371 (2008), 28–32.
122. Negre-Salvayre, A., Vieira, O., Escargueil-Blanc, I., Salvayre, R., Oxidized LDL and 4-hydroxynonenal modulate tyrosine kinase receptor activity. Mol. Asp. Med. 24 (2003), 251–261.
123. Aldini, G., Dalle-Donne, I., Vistoli, G., Maffei Facino, R., Carini, M., Covalent modification of actin by 4-hydroxy-trans-2-nonenal (HNE): LC-ESI–MS/MS evidence for Cys374 Michael adduction. J. Mass Spectrom. 40 (2005), 946–954.
124. Carbone, D.L., Doorn, J.A., Petersen, D.R., 4-Hydroxynonenal regulates 26S proteasomal degradation of alcohol dehydrogenase. Free. Radic. Biol. Med. 37 (2004), 1430–1439.
125. Doorn, J.A., Hurley, T.D., Petersen, D.R., Inhibition of human mitochondrial aldehyde dehydrogenase by 4-hydroxynon-2-enal and 4-oxonon-2-enal. Chem. Res. Toxicol. 19 (2006), 102–110.
126. Birben, E., Sahiner, U.M., Sackesen, C., Erzurum, S., Kalayci, O., Oxidative stress and antioxidant defense. World Allergy Organ J. 5 (2012), 9–19.
127. Houtkooper, R.H., Mouchiroud, L., Ryu, D., Moullan, N., Katsyuba, E., Knott, G., et al. Mitonuclear protein imbalance as a conserved longevity mechanism. Nature 497 (2013), 451–457.
128. Solon-Biet, S.M., McMahon, A.C., Ballard, J.W., Ruohonen, K., Wu, L.E., Cogger, V.C., et al. The ratio of macronutrients, not caloric intake, dictates cardiometabolic health, aging, and longevity in ad libitum-fed mice. Cell Metab. 19 (2014), 418–430.
129. Haberzettl, P., Hill, B.G., Oxidized lipids activate autophagy in a JNK-dependent manner by stimulating the endoplasmic reticulum stress response. Redox Biol. 1 (2013), 56–64.
130. Ciechanover, A., Brundin, P., The ubiquitin proteasome system in neurodegenerative diseases: sometimes the chicken, sometimes the egg. Neuron 40 (2003), 427–446.
131. Schlossarek, S., Carrier, L., The ubiquitin–proteasome system in cardiomyopathies. Curr. Opin. Cardiol. 26 (2011), 190–195.
132. Okada, K., Wangpoengtrakul, C., Osawa, T., Toyokuni, S., Tanaka, K., Uchida, K., 4-Hydroxy-2-nonenal-mediated impairment of intracellular proteolysis during oxidative stress. Identification of proteasomes as target molecules. J. Biol. Chem. 274 (1999), 23787–23793.
133. Jung, T., Grune, T., The proteasome and the degradation of oxidized proteins: Part I—structure of proteasomes. Redox Biol. 1 (2013), 178–182.
134. Ferrington, D.A., Kapphahn, R.J., Catalytic site‐specific inhibition of the 20S proteasome by 4‐hydroxynonenal. FEBS Lett. 578 (2004), 217–223.
135. Giordano, S., Darley-Usmar, V., Zhang, J., Autophagy as an essential cellular antioxidant pathway in neurodegenerative disease. Redox Biol. 2 (2014), 82–90.
136. Lee, J., Giordano, S., Zhang, J., Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling. Biochem. J. 441 (2012), 523–540.
137. Zhao, Y., Xiong, X., Sun, Y., DEPTOR, an mTOR inhibitor, is a physiological substrate of SCF βTrCP E3 ubiquitin ligase and regulates survival and autophagy. Mol. Cell 44 (2011), 304–316.
138. Wei, Y., Autophagic induction of amyotrophic lateral sclerosis-linked Cu/Zn superoxide dismutase 1 G93A mutant in NSC34 cells. Neural Regen. Res. 9 (2014), 16–24.
139. Goode, A., Butler, K., Long, J., Cavey, J., Scott, D., Shaw, B., et al. Defective recognition of LC3B by mutant SQSTM1/p62 implicates impairment of autophagy as a pathogenic mechanism in ALS-FTLD. Autophagy 12 (2016), 1094–1104.
140. Jin, S., Autophagy, mitochondrial quality control, and oncogenesis. Autophagy 2 (2006), 80–84.
141. Dodson, M., Liang, Q., Johnson, M.S., Redmann, M., Fineberg, N., Darley-Usmar, V.M., et al. Inhibition of glycolysis attenuates 4-hydroxynonenal-dependent autophagy and exacerbates apoptosis in differentiated SH-SY5Y neuroblastoma cells. Autophagy 9 (2013), 1996–2008.
142. Ray, P.D., Huang, B.W., Tsuji, Y., Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal. 24 (2012), 981–990.
143. Zheng, R., Po, I., Mishin, V., Black, A.T., Heck, D.E., Laskin, D.L., et al. The generation of 4-hydroxynonenal, an electrophilic lipid peroxidation end product, in rabbit cornea organ cultures treated with UVB light andnitrogen mustard. Toxicol. Appl. Pharmacol. 272 (2013), 345–355.
144. Haberzettl, P., Hill, B.G., Oxidized lipids activate autophagy in a JNK-dependent manner by stimulating the endoplasmic reticulum stress response. Redox Biol. 1 (2013), 56–64.
145. Sampey, B.P., Carbone, D.L., Doorn, J.A., Drechsel, D.A., Petersen, D.R., 4-Hydroxy-2-nonenal adduction of extracellular signal-regulated kinase (Erk) and the inhibition of hepatocyte Erk-Est–like protein-1-activating protein-1 signal transduction. Mol. Pharmacol. 71 (2007), 871–883.
146. Lin, M.H., Yen, J.H., Weng, C.Y., Wang, L., Ha, C.L., Wu, M.J., Lipid peroxidation end product 4-hydroxy-trans-2-nonenal triggers unfolded protein response and heme oxygenase-1 expression in PC12 cells: roles of ROS and MAPK pathways. Toxicology 315 (2014), 24–37.
147. Tian, H., Ye, X., Hou, X., Yang, X., Yang, J., Wu, C., SVCT2, a potential therapeutic target, protects against oxidative stress during ethanol-induced neurotoxicity via JNK/p38 MAPKs, NF-κB and miRNA125a-5p. Free Radic. Biol. Med. 96 (2016), 362–373.
148. Shibata, N., Kato, Y., Inose, Y., Hiroi, A., Yamamoto, T., Motikawa, S., et al. 4-hydroxy-2-nonenal upregulates and phosphorylates cytosolic phospholipase A2 in cultured Ra2 microglial cells via MAPK pathways. Neuropathology 31 (2011), 122–128.
149. Moon, K.H., Tajuddin, N., Brown, J., Neafsey, E.J., Kim, H.Y., Collins, M.A., Phospholipase A2, oxidative stress, and neurodegeneration in binge ethanol‐treated organotypic slice cultures of developing rat brain. Alcohol Clin. Exp. Res. 38 (2014), 161–169.
150. Łuczaj, W., Moniuszko, A., Jarocka-Karpowicz, I., Pancewicz, S., Andrisic, L., Zarkovic, N., Skrzydlewska, E., Tick-borne encephalitis-lipid peroxidation and its consequences. Scand. J. Clin. Lab. Investig. 76 (2016), 1–9.
151. Kumagai, T., Usami, H., Matsukawa, N., Nakashima, F., Chikazawa, M., Shibata, T., et al. Functional interaction between cyclooxygenase-2 and p53 in response to an endogenous electrophile. Redox Biol. 4 (2015), 74–86.
152. Mochly-Rosen, D., Das, K., Grimes, K.V., Protein kinase C, an elusive therapeutic target?. Nat. Rev. Drug Discov. 11 (2012), 937–957.
153. Turban, S., Hajduch, E., Protein kinase C isoforms: mediators of reactive lipid metabolites in the development of insulin resistance. FEBS Lett. 585 (2011), 269–274.
154. Schwarzer, E., Müller, O., Arese, P., Siems, W.G., Grune, T., Increased levels of 4‐hydroxynonenal in human monocytes fed with malarial pigment hemozoin A possible clue for hemozoin toxicity. FEBS Lett. 388 (1996), 119–122.
155. Chiarpotto, E., Domenicotti, C., Paola, D., Vitali, A., Nitti, M., Pronzato, M.A., et al. Regulation of rat hepatocyte protein kinase C β isoenzymes by the lipid peroxidation product 4-hydroxy-2,3-nonenal: a signaling pathway to modulate vesicular transport of glycoproteins. Hepatology 29 (1999), 1565–1572.
156. Harry, R.S., Hiatt, L.A., Kimmel, D.W., Carney, C.K., Halfpenny, K.C., Cliffel, D.E., et al. Metabolic impact of 4-hydroxynonenal on macrophage-like RAW264.7 function and activation. Chem. Res. Toxicol. 25 (2012), 1643–1651.
157. Molina-Jijón, E., Rodríguez-Muñoz, R., del Carmen Namorado, M., Pedraza-Chaverri, J., Reyes, J.L., Oxidative stress induces claudin-2 nitration in experimental type 1 diabetic nephropathy. Free Radic. Biol. Med. 72 (2014), 162–175.
158. Zhang, J., Burrington, C.M., Davenport, S.K., Johnson, A.K., Horsman, M.J., Chowdhry, S., et al. PKCδ regulates hepatic triglyceride accumulation and insulin signaling in Leprdb/db mice. Biochem. Biophys. Res. Commun. 450 (2014), 1619–1625.
159. Clarke, P., Debiasi, R.L., Goody, R., Hoyt, C.C., Richardson-Burns, S., Tyler, K.L., Mechanisms of reovirus-induced cell death and tissue injury: role of apoptosis and virus-induced perturbation of host-cell signaling and transcription factor activation. Viral Immunol. 18 (2005), 89–115.
160. Tell, G., Quadrifoglio, F., Tiribelli, C., Kelley, M.R., The many functions of APE1/Ref-1: not only a DNA repair enzyme. Antioxid. Redox Signal. 11 (2009), 601–619.
161. Novo, E., Parola, M., Redox mechanisms in hepatic chronic wound healing and fibrogenesis. Fibrogenesis Tissue Repair, 1, 2008, 1, 10.1186/1755-1536-1-5.
162. Busso, C.S., Lake, M.W., Izumi, T., Posttranslational modification of mammalian AP endonuclease (APE1). Cell. Mol. Life Sci. 67 (2010), 3609–3620.
163. Thakur, S., Sarkar, B., Cholia, R.P., Gautam, N., Dhiman, M., Mantha, A.K., APE1/Ref-1 as an emerging therapeutic target for various human diseases: phytochemical modulation of its functions. Exp. Mol. Med. 46 (2014), 1–21.
164. Kensler, T.W., Wakabayashi, N., Biswal, S., Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu. Rev. Pharmacol. Toxicol. 47 (2007), 89–116.
165. Li, W., Thakor, N., Xu, E.Y., Huang, Y., Chen, C., Yu, R., et al. An internal ribosomal entry site mediates redox-sensitive translation of Nrf2. Nucleic Acids Res. 38 (2010), 778–788.
166. Zhang, Y., Hou, Y., Liu, C., Li, Y., Guo, W., Wu, J.L., et al. Identification of an adaptor protein that facilitates Nrf2-Keap1 complex formation and modulates antioxidant response. Free Radic. Biol. Med. 97 (2016), 38–49.
167. Gruber, F., Ornelas, C.M., Karner, S., Narzt, M.S., Nagelreiter, I.M., Gschwandtner, M., et al. Nrf2 deficiency causes lipid oxidation, inflammation, and matrix-protease expression in DHA-supplemented and UVA-irradiated skin fibroblasts. Free Radic. Biol. Med. 88 (2015), 439–451.
168. Lin, P.L., Chang, J.T., Wu, D.W., Huang, C.C., Lee, H., Cytoplasmic localization of Nrf2 promotes colorectal cancer with more aggressive tumors via upregulation of PSMD4. Free Radic. Biol. Med. 95 (2016), 121–132.
169. Kansanen, E., Jyrkkänen, H.K., Levonen, A.L., Activation of stress signaling pathways by electrophilic oxidized and nitrated lipids. Free Radic. Biol. Med. 52 (2012), 973–982.
170. Levonen, A.L., Landar, A., Ramachandran, A., Ceaser, E.K., Dickinson, D.A., Zanoni, G., et al. Cellular mechanisms of redox cell signalling: role of cysteine modification in controlling antioxidant defences in response to electrophilic lipid oxidation products. Biochem. J. 378 (2004), 373–382.
171. Zhang, Y., Ahn, Y.H., Benjamin, I.J., Honda, T., Hicks, R.J., Calabrese, V., et al. HSF1-dependent upregulation of Hsp70 by sulfhydryl-reactive inducers of the KEAP1/NRF2/ARE pathway. Chem. Biol. 18 (2011), 1355–1361.
172. Kimura, M., Yamamoto, T., Zhang, J., Itoh, K., Kyo, M., Kamiya, T., et al. Molecular basis distinguishing the DNA binding profile of Nrf2-Maf heterodimer from that of Maf homodimer. J. Biol. Chem. 282 (2007), 33681–33690.
173. Fernández-Millán, E., Martín, M.A., Goya, L., Lizárraga-Mollinedo, E., Escrivá, F., Ramos, S., et al. Glucagon-like peptide-1 improves beta-cell antioxidant capacity via extracellular regulated kinases pathway and Nrf2 translocation. Free Radic. Biol. Med. 95 (2016), 16–26.
174. Pi, J., Bai, Y., Reece, J.M., Williams, J., Liu, D., Freeman, M.L., et al. Molecular mechanism of human Nrf2 activation and degradation: role of sequential phosphorylation by protein kinase CK2. Free Radic. Biol. Med. 42 (2007), 1797–1806.
175. Ishikawa, M., Numazawa, S., Yoshida, T., Redox regulation of the transcriptional repressor Bach1. Free Radic. Biol. Med. 38 (2005), 1344–1352.
176. Fishel, M.L., Wu, X., Devlin, C.M., Logsdon, D.P., Jiang, Y., Luo, M., et al. Apurinic/apyrimidinic endonuclease/redox factor-1 (APE1/Ref-1) redox function negatively regulates NRF2. J. Biol. Chem. 290 (2015), 3057–3068.
177. Done, A.J., Gage, M.J., Nieto, N.C., Traustadóttir, T., Exercise-induced Nrf2-signaling is impaired in aging. Free Radic. Biol. Med. 96 (2016), 130–138.
178. López-Bernardo, E., Anedda, A., Sánchez-Pérez, P., Acosta-Iborra, B., Cadenas, S., 4-Hydroxynonenal induces Nrf2-mediated UCP3 upregulation in mouse cardiomyocytes. Free Radic. Biol. Med. 88 (2015), 427–438.
179. Wu, K.L., Wu, C.W., Chao, Y.M., Hung, C.Y., Chan, J.Y., Impaired Nrf2 regulation of mitochondrial biogenesis in rostral ventrolateral medulla on hypertension induced by systemic inflammation. Free Radic. Biol. Med. 97 (2016), 58–74.
180. Cheng, X., Ku, C.H., Siow, R.C., Regulation of the Nrf2 antioxidant pathway by microRNAs: new players in micromanaging redox homeostasis. Free Radic. Biol. Med. 64 (2013), 4–11.
181. Franklin, C.C., Backos, D.S., Mohar, I., White, C.C., Forman, H.J., Kavanagh, T.T., Structure, function, and post-translational regulation of the catalytic and modifier subunits of glutamate cysteine ligase. Mol. Asp. Med. 30 (2009), 86–98.
182. Stark, A., Brennecke, J., Bushati, N., Russell, R.B., Cohen, S.M., Animal MicroRNAs confer robustness to gene expression and have a significant impact on 3′ UTR evolution. Cell 123 (2005), 1133–1146.
183. Pizzimenti, S., Ferracin, M., Sabbioni, S., Toaldo, C., Pettazzoni, P., Dianzani, M.U., et al. MicroRNA expression changes during human leukemic HL-60 cell differentiation induced by 4-hydroxynonenal, a product of lipid peroxidation. Free Radic. Biol. Med. 46 (2009), 282–288.
184. Eades, G., Yang, M., Yao, Y., Zhang, Y., Zhou, Q., miR-200a regulates Nrf2 activation by targeting Keap1 mRNA in breast cancer cells. J. Biol. Chem. 286 (2011), 40725–40733.
185. Wu, H., Kong, L., Tan, Y., Epstein, P.N., Zeng, J., Gu, J., et al. C66 ameliorates diabetic nephropathy in mice by both upregulating NRF2 function via increase in miR-200a and inhibiting miR-21. Diabetologia 2016:59 (2016), 1558–1568.
186. Yang, F., Zhang, L., Wang, F., Wang, Y., Huo, X.S., Yin, Y.X., et al. Modulation of the unfolded protein response is the core of microRNA-122-involved sensitivity to chemotherapy in hepatocellular carcinoma. Neoplasia 13 (2011), 590–600.
187. Hou, W., Tian, Q., Steuerwald, N.M., Schrum, L.W., Bonkovsky, H.L., The let-7 microRNA enhances heme oxygenase-1 by suppressing Bach1 and attenuates oxidant injury in human hepatocytes. Biochim. Biophys. Acta 1819 (2012), 1113–1122.
188. Pulkkinen, K.H., Ylä-Herttuala, S., Levonen, A.L., Heme oxygenase 1 is induced by miR-155 via reduced BACH1 translation in endothelial cells. Free Radic. Biol. Med. 51 (2011), 2124–2131.
189. Csak, T., Bala, S., Lippai, D., Kodys, K., Catalano, D., Iracheta-Vellve, A., Szabo, G., MicroRNA-155 deficiency attenuates liver steatosis and fibrosis without reducing inflammation in a mouse model of steatohepatitis. PLoS One, 10, 2015, e0129251.
190. Narasimhan, M., Patel, D., Vedpathak, D., Rathinam, M., Henderson, G., Mahimainathan, L., Identification of novel microRNAs in post-transcriptional control of Nrf2 expression and redox homeostasis in neuronal, SH-SY5Y cells. PLoS One, 7, 2012, e51111.
191. Liu, Q., Ullery, J., Zhu, J., Liebler, D.C., Marnett, L.J., Zhang, B., RNA-seq data analysis at the gene and CDS levels provides a comprehensive view of transcriptome responses induced by 4-hydroxynonenal. Mol. Biosyst. 9 (2013), 3036–3046.
192. Cun, Y., Dai, N., Li, M., Xiong, C., Zhang, Q., Sui, J., et al. APE1/Ref-1 enhances DNA binding activity of mutant p53 in a redox-dependent manner. Oncol. Rep. 31 (2014), 901–909.
193. Liu, Y., He, Y., Jin, A., Tikunov, A.P., Zhou, L., Tollini, L.A., et al. Ribosomal protein–Mdm2–p53 pathway coordinates nutrient stress with lipid metabolism by regulating MCD and promoting fatty acid oxidation. Proc. Natl. Acad. Sci. USA 111 (2014), E2414–E2422.
194. Drayman, N., Ben-Nun-Shaul, O., Butin-Israeli, V., Srivastava, R., Rubinstein, A.M., Mock, C.S., et al. p53 elevation in human cells halt SV40infection by inhibiting T-ag expression. Oncotarget 7 (2016), 52643–52660.
195. Suzuki, H., Ito, R., Ikeda, K., Tamura, T.A., TATA-binding protein (TBP)-like protein is required for p53-dependent transcriptional activation of upstream promoter of p21Waf1/Cip1 gene. J. Biol. Chem. 287 (2012), 19792–19803.
196. Silva, G., Marins, M., Fachin, A.L., Lee, S.H., Baek, S.J., Anti‐cancer activity of trans‐chalcone in osteosarcoma: Involvement of Sp1 and p53. Mol. Carcinog. 55 (2015), 1438–1448.
197. Hock, A.K., Vousden, K.H., The role of ubiquitin modification in the regulation of p53. Biochim. Biophys. Acta 1843 (2014), 137–149.
198. Can, G., Akpinar, B., Baran, Y., Zhivotovsky, B., Olsson, M., 5-Fluorouracil signaling through a calcium–calmodulin-dependent pathway is required for p53 activation and apoptosis in colon carcinoma cells. Oncogene 32 (2013), 4529–4538.
199. Meng, X., Laidler, L.L., Kosmacek, E.A., Yang, S., Xiong, Z., Zhu, D., et al. Induction of mitotic cell death by overriding G2/M checkpoint in endometrial cancer cells with non-functional p53. Gynecol. Oncol. 128 (2013), 461–469.
200. Sun, A., Zou, Y., Wang, P., Xu, D., Gong, H., Wang, S., et al. Mitochondrial aldehyde dehydrogenase 2 plays protective roles in heart failure after myocardial infarction via suppression of the cytosolic JNK/p53 pathway in mice. J. Am. Heart Assoc., 3, 2014, e000779.
201. Buizza, L., Cenini, G., Lanni, C., Ferrari-Toninelli, G., Prandelli, C., Govoni, S., et al. Conformational altered p53 as an early marker of oxidative stress in Alzheimer's disease. PLoS One, 7, 2012, e29789.
202. Cenini, G., Sultana, R., Memo, M., Butterfield, D.A., Elevated levels of pro‐apoptotic p53 and its oxidative modification by the lipid peroxidation product, HNE, in brain from subjects with amnestic mild cognitive impairment and Alzheimer's disease. J. Cell. Mol. Med. 12 (2008), 987–994.
203. Barone, E., Cenini, G., Sultana, R., Di Domenico, F., Fiorini, A., Perluigi, M., et al. Lack of p53 decreases basal oxidative stress levels in the brain through upregulation of thioredoxin-1, biliverdin reductase-A, manganese superoxide dismutase, and nuclear factor kappa-B. Antioxid. Redox Signal. 16 (2012), 1407–1420.
204. Luqman, S., Pezzuto, J.M., NFκB: a promising target for natural products in cancer chemoprevention. Phytother. Res. 24 (2010), 949–963.
205. Chang, T.P., Vancurova, I., Al-Mulla, F., Bitar, M.S., Thiery, J.P., Zea, T.T., et al. NFκB function and regulation in cutaneous T-cell lymphoma. Am. J. Cancer Res. 3 (2013), 433–445.
206. Hayden, M.S., Ghosh, S., Signaling to NF-kappaB. Genes Dev. 18 (2004), 2195–2204.
207. Massaeli, H., Jalali, S., Viswanathan, D., Mesaeli, N., Loss of calreticulin function decreases NFκB activity by stabilizing IκB protein. Biochim. Biophys. Acta 1843 (2014), 2385–2393.
208. Jang, E.J., Kim, D.H., Lee, B., Lee, E.K., Chung, K.W., Moon, K.M., et al. Activation of proinflammatory signaling by 4-hydroxynonenal-Src adducts in aged kidneys. Oncotarget 7 (2016), 50864–50874.
209. Ji, C., Kozak, K.R., Marnett, L.J., IκB kinase, a molecular target for inhibition by 4-hydroxy-2-nonenal. J. Biol. Chem. 276 (2001), 18223–18228.
210. Yamada, T., Tsuda, M., Wagatsuma, T., Fujioka, Y., Fujioka, M., Satoh, A.O., et al. Receptor activator of NF-κB ligand induces cell adhesion and integrin α2 expression via NF-κB in head and neck cancers. Sci. Rep., 6, 2016, 23545.
211. Gurusamy, N., Malik, G., Gorbunov, N.V., Das, D.K., Redox activation of Ref-1 potentiates cell survival following myocardial ischemia reperfusion injury. Free Radic. Biol. Med. 43 (2007), 397–407.
212. Youn, G.S., Lee, K.W., Choi, S.Y., Park, J., Overexpression of HDAC6 induces pro-inflammatory responses by regulating ROS-MAPK-NF-κB/AP-1 signaling pathways in macrophages. Free Radic. Biol. Med. 97 (2016), 14–23.
213. Mitomo, K., Nakayama, K., Fujimoto, K., Sun, X., Seki, S., Yamamoto, K., Two different cellular redox systems regulate the DNA-binding activity of the p50 subunit of NF-kappa B in vitro. Gene 145 (1994), 197–203.
214. Heilman, J.M., Burke, T.J., McClain, C.J., Watson, W.H., Transactivation of gene expression by NF-κB is dependent on thioredoxin reductase activity. Free Radic. Biol. Med. 51 (2011), 1533–1542.
215. Marshall, H.E., Stamler, J.S., Inhibition of NF-kappa B by S-nitrosylation. Biochemistry 40 (2001), 1688–1693.
216. Pineda-Molina, E., Klatt, P., Vazquez, J., Marina, A., Garcia de Lacoba, M., Perez-Sala, D., et al. Glutathionylation of the p50 subunit of NF-kappaB: a mechanism for redox-induced inhibition of DNA binding. Biochemistry 40 (2001), 14134–14142.
217. Kim, Y.S., Park, Z.Y., Kim, S.Y., Jeong, E., Lee, J.Y., Alteration of Toll-like receptor 4 activation by 4-hydroxy-2-nonenal mediated by the suppression of receptor homodimerization. Chem. Biol. Interact. 182 (2009), 59–66.
218. Azzolina, A., Bongiovanni, A., Lampiasi, N., Substance P induces TNF-α and IL-6 production through NFκB in peritoneal mast cells. Biochim. Biophys. Acta 1643 (2003), 75–83.
219. S.H. Baek, J.N. Min, E.M. Park, M.Y. Han, Y.S. Lee, Y.J. Lee, et al. Role of small heat shock protein HSP25 in radioresistance and glutathione‐redox cycle. J. Cell. Physiol., vol. 200(183), pp. 100–107.
220. Samarasinghe, B., Wales, C.T., Taylor, F.R., Jacobs, A.T., Heat shock factor 1 confers resistance to Hsp90 inhibitors through p62/SQSTM1 expression and promotion of autophagic flux. Biochem. Pharmacol. 87 (2014), 445–455.
221. Wang, Y., Gibney, P.A., West, J.D., Morano, K.A., The yeast Hsp70 Ssa1 is a sensor for activation of the heat shock response by thiol-reactive compounds. Mol. Biol. Cell 23 (2012), 3290–3298.
222. Carbone, D.L., Doorn, J.A., Kiebler, Z., Sampey, B.P., Petersen, D.R., Inhibition of Hsp72-mediated protein refolding by 4-hydroxy-2-nonenal. Chem. Res. Toxicol. 17 (2004), 1459–1467.
223. Connor, R.E., Marnett, L.J., Liebler, D.C., Protein-selective capture to analyze electrophile adduction of hsp90 by 4-hydroxynonenal. Chem. Res. Toxicol. 24 (2011), 1275–1282.
224. Nakai, A., Molecular basis of HSF regulation. Nat. Struct. Mol. Biol. 23 (2016), 93–95.
225. Jacobs, A.T., Marnett, L.J., HSF1-mediated BAG3 expression attenuates apoptosis in 4-hydroxynonenal treated colon cancer cells via stabilization of antiapoptotic Bcl-2 proteins. J. Biol. Chem. 284 (2009), 9176–9183.
226. Kaarniranta, K., Ryhänen, T., Karjalainen, H.M., Lammi, M.J., Suuronen, T., Huhtala, A., et al. Geldanamycin increases 4-hydroxynonenal (HNE)-induced cell death in human retinal pigment epithelial cells. Neurosci. Lett. 382 (2005), 185–190.
227. Gil, L., Siems, W., Mazurek, B., Gross, J., Schroeder, P., Voss, P., Grune, T., Age-associated analysis of oxidative stress parameters in human plasma and erythrocytes. Free Radic. Res. 40 (2016), 495–505.
228. Negre-Salvayre, A., Auge, N., Ayala, V., Basaga, H., Boada, J., Brenke, R., Chapple, S., Cohen, G., Feher, J., Grune, T., et al. Pathological aspects of lipid peroxidation. Free Radic. Res. 44 (2010), 1125–1171.
229. Zarkovic, N., Cipak, A., Jaganjac, M., Borovic, S., Zarkovic, K., Pathophysiological relevance of aldehydic protein modifications. J. Proteom. 92 (2013), 239–247.
230. Levine, R.L., Stadtman, E.R., Oxidative modification of proteins during aging. Exp. Gerontol. 36 (2001), 1495–1502.
231. Ahmed, E.K., Picot, C.R., Bulteau, A.-L., Friguet, B., Protein oxidative modifications and replicative senescence of WI-38 human embryonic fibroblasts. Ann. N. Y. Acad. Sci. 1119 (2007), 88–96.
232. Zarkovic, K., Larroque-Cardoso, P., Pucelle, M., Salvayre, R., Waeg, G., Nègre-Salvayre, A., et al. Elastin aging and lipid oxidation products in human aorta. Redox Biol. 4 (2015), 109–117.
233. Zhang, X.M., Guo, L., Huang, X., Li, Q.M., Chi, M.H., 4‐hydroxynonenal regulates TNF‐α gene transcription indirectly via ETS1 and microRNA‐29b in human adipocytes induced from adipose tissue‐derived stromal cells. Anat. Rec. 299 (2016), 1145–1152.
234. Benedetti, E., D'Angelo, B., Cristiano, L., Di Giacomo, E., Fanelli, F., Moreno, S., et al. Involvement of peroxisome proliferator-activated receptor β/δ (PPAR β/δ) in BDNF signaling during aging and in Alzheimer disease: possible role of 4-hydroxynonenal (4-HNE). Cell Cycle 13 (2014), 1335–1344.
235. Sinha-Hikim, I., Sinha-Hikim, A.P., Parveen, M., Shen, R., Goswami, R., Tran, P., et al. Long-term supplementation with a cystine-based antioxidant delays loss of muscle mass in aging. J. Gerontol. A Biol. Sci. Med. Sci. 68 (2013), 749–759.
236. Shringarpure, R., Grune, T., Sitte, N., Davies, K.J.A., 4-hydroxynonenal-modified amyloid-β peptide inhibits the proteasome: possible importance in Alzheimer's disease. Cell. Mol. Life Sci. 57 (2000), 1802–1809.
237. Jiang, T., Chen, N., Zhao, F., Wang, X.J., Kong, B., Zheng, W., et al. High levels of Nrf2 determine chemoresistance in type II endometrial cancer. Cancer Res. 70 (2010), 5486–5496.